SELECTED PEER-REVIEWED PUBLICATIONS

Mavrikaki M, Pantano L, Potter D, Rogers-Grazado MA, Anastasiadou E, Slack FJ, Amr SS, Ressler KJ, Daskalakis NP, Chartoff E. Sex-Dependent Changes in miRNA Expression in the Bed Nucleus of the Stria Terminalis Following Stress. Front Mol Neurosci. 2019. 12:1-14. PMID: 31636537.

Page S Mavrikaki MM, Lintz T, Puttick D, Roberts E, Rosen H, Carroll FI, Carlezon WA, Chartoff EH. Behavioral pharmacology of novel kappa opioid receptor antagonists in rats. Int J Neuropsychopharmacol. 2019. 22(11):735-745. PMID: 31613314

Becker J and Chartoff E. Sex Differences in neural mechanisms mediating reward and addiction. Neuropsychopharmacology. 2018; 44:166-183. Review.

Mavrikaki M, Anastasiadou E, Ozdemir RA, Potter D, Helmholz C, Slack FJ, Chartoff EH. Overexpression of miR-9 in the Nucleus Accumbens Increases Oxycodone Self-Administration. Int J Neuropsychopharmacol. 2019. 22(6):383-393. PMID: 30989210.

Conway SM, Puttick D, Russell S, Potter D, Roitman MF, Chartoff EH. Females are less sensitive than males to the motivational- and dopamine-suppressing effects of kappa opioid receptor activation. Neuropharmacology. 2019. 146:231-241. PMID: 30528327.

Mavrikaki M, Pravetoni M, Page S, Potter D, Chartoff E. Oxycodone self-administration in male and female rats. Psychopharmacology. 2017; 234(6):977-987. PMID:28127624.

Russell SE, Puttick DJ, Sawyer AM, Potter DN, Mague S, Carlezon WA Jr., Chartoff EH. Nucleus accumbens AMPA receptors are necessary for morphine withdrawal-induced negative affective states in rats. J. Neurosci. 2016; 36(21):5748-5762. PMID:27225765.

Chartoff EH, Ebner SR, Sparrow A, Potter D, Baker PM, Ragozzino ME, Roitman MF. Relative timing between kappa opioid receptor activation and cocaine determines the impact on reward and dopamine release. Neuropsychopharmacology. 2015; 41(4):989-1002. PMID: 26239494.

Yap JJ, Chartoff EH, Holly EN, Potter DN, Carlezon WA Jr, Miczek KA. Social defeat stress-induced sensitization and escalated cocaine self-administration: the role of ERK signaling in the rat ventral tegmental area. Psychopharm. 2014; 232(9):1555-1569. PMID: 25373870.

Pravetoni M, Pentel PR, Potter DN, Chartoff EH, Tally L, LeSAge MG. Effects of an oxycodone conjugate vaccine on oxycodone self-administration and oxycodone-induced brain gene expression in rats. PLoS One. 2014; 9(7):e101807. PMID: 25025380.

Russell SE, Rachlin AB, Smith KL, Muschamp J, Berry L, Zhao Z, Chartoff EH.  Sex differences in sensitivity to the depressive-like effects of the kappa opioid receptor agonist U-50488 in rats. Biol. Psychiatry. 2014; 76(3):213-222. PMID: 24090794.

Chartoff EH, Sawyer A, Rachlin A, Potter D, Pliakas A, Carlezon WA, Jr. Blockade of kappa-opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats. Neuropharmacology. 2012; 62(1):167-176. PMID: 21736885.

Potter DN, Damez-Werno D, Carlezon WA Jr., Cohen BM, Chartoff EH.  Repeated exposure to the kappa-opioid receptor agonist salvinorin A modulates extracellular signal regulated kinase and reward sensitivity. Biol Psychiatry. 2011; 70(8):744-753. PMID: 21757186.

Chartoff EH, Papadopoulou M, MacDonald ML, Parsegian A, Potter D, Konradi C, Carlezon WA Jr. Desipramine reduces stress-activated dynorphin expression and CREB phosphorylation in NAc tissue. Mol Pharmacol. 2009; 75(3):704-712. PMID:19106229.

Carlezon WA Jr, Chartoff EH. Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat Protoc. 2007; 2(11):2987-2995. PMID: 18007634.

Chartoff EH, Mague SD, Barhight MF, Smith AM, Carlezon WA Jr. Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal. J Neurosci. 2006; 26(24):6450-6457. PMID: 16775132.

Goussakov I*, Chartoff EH*, Tsvetkov E, Gerety LP, Meloni EG, Carlezon WA Jr, Bolshakov VY. LTP in the lateral amygdala during cocaine withdrawal. Eur J Neurosci. 2006; 23(1):239-250. PMID: 16420433. (*Co-first authors)

Chartoff EH, Heusner CL, Palmiter RD. Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists. Neuropsychopharmacology. 2005; 30(7):1324-1333. PMID: 15688082.

CHARTOFF LAB

115 Mill Street 
Belmont, MA, USA

©2017 BY CHARTOFF LAB. PROUDLY CREATED WITH WIX.COM